Order Durolane Injection for Clinics

Durolane is a single-injection, stabilized hyaluronic acid gel for intra-articular use, supplied as a 3 mL prefilled syringe containing 60 mg of hyaluronic acid (20 mg/mL). Licensed clinics, orthopedic practices, sports medicine groups, and hospital departments can buy Durolane wholesale for treatment-room use in knee osteoarthritis. One syringe delivers the full treatment, so an injection visit stays a single appointment.

How Durolane works in the joint

Hyaluronic acid is a normal part of synovial fluid. It helps the joint glide and spread load across the cartilage surface. In osteoarthritis, the amount and quality of that fluid fall, and the joint cushions movement less well.

Durolane is made using NASHA technology, which stands for non-animal stabilized hyaluronic acid. The hyaluronic acid is produced by bacterial fermentation, then stabilized so it resists breakdown inside the joint. The manufacturer’s instructions for use describe this slower breakdown as the basis for a single 3 mL injection instead of a weekly series.

In the United States, Durolane is regulated as a Class III device with premarket approval, not as a drug. Its action is mechanical: it supplements joint fluid to support lubrication and shock absorption. It does not rebuild cartilage and does not change joint structure.

Why it matters: A one-visit protocol frees two to four injection slots per treated knee compared with a multi-dose series.

Approved use and clinical fit

FDA-approved labeling covers treatment of pain in osteoarthritis of the knee in patients who have not responded well enough to conservative non-pharmacologic care and simple analgesics such as acetaminophen. In day-to-day practice, that means exercise therapy, activity modification, weight management, and oral analgesics have already been tried.

Durolane is not a treatment for acute joint injury, inflammatory arthritis, or joint infection. Use in joints other than the knee, such as the hip or shoulder, falls outside the approved US indication and would be off-label; that use is not promoted here. Confirm the osteoarthritis diagnosis by exam and imaging before planning viscosupplementation, and document the conservative measures already attempted.

Clinics usually place Durolane in a stepped knee pathway: physical therapy and analgesics first, then intra-articular options, with surgical referral reserved for patients who continue to decline. Because the course is one injection, it suits patients who travel for care or who struggle to attend several weekly visits.

Ordering Durolane 60mg/3ml and planning clinic stock

Licensed clinics and healthcare professionals can order the Durolane 60mg/3ml prefilled syringe and view current wholesale pricing with the item. Med Wholesale Supplies is a wholesale supplier of aesthetic, orthopedic and medical products to clinics, hospitals and medical professionals, operating since 2013. We may review order details and professional-use documentation for restricted clinical items before release.

Inventory math stays simple with a single-injection product. Count booked knee injection visits for the period, add bilateral cases as two syringes, then hold a small buffer for rescheduled patients. Shorter courses also reduce the number of part-used treatment plans left open if a patient stops attending.

Practices that buy Durolane wholesale often stock it next to their standard aseptic injection supplies: skin prep, sterile gloves and drapes, aspiration syringes and needles for effusion removal, and sharps containers. Keeping those items at the same par level prevents a half-ready injection tray on clinic day.

Patient selection, contraindications, and precautions

Screen every patient against the instructions for use before injecting. Key points from device labeling for intra-articular hyaluronic acid products include the following:

• Do not inject if there is a known hypersensitivity to hyaluronic acid preparations.
• Do not inject into a joint with suspected or confirmed infection, or through skin that is infected or diseased at the planned entry site.
• Avoid injection where there is significant venous or lymphatic stasis in the treated leg.
• Safety and effectiveness have not been established in pregnancy, in breastfeeding, or in children.
• Use caution in patients on anticoagulants or with bleeding disorders, and in those with uncontrolled diabetes or immunosuppression who carry higher infection risk.
• Do not inject intravascularly; confirm needle position and aspirate before delivery.

Aspirate a tense effusion before injecting, since excess fluid dilutes the gel and raises pressure in the joint. Advise patients to avoid strenuous weight-bearing activity for about two days after the injection, as described in the instructions for use.

Expected reactions and post-injection monitoring

Most reported effects are local and short-lived. Patients may notice pain, swelling, warmth, stiffness, or a feeling of fullness in the treated knee for a few days. Cold packs and simple analgesics are commonly used for these transient symptoms.

Less often, an acute inflammatory flare with marked pain and effusion can follow intra-articular hyaluronic acid injection. Septic arthritis is rare but serious and is the main reason strict aseptic technique matters. Tell patients to report fever, spreading redness, severe or worsening pain, or inability to bear weight, and to seek urgent care rather than waiting for a routine follow-up.

Record the baseline pain and function score, the injected knee, and the date, then plan a review at the interval your protocol uses. That record supports later decisions about repeat injection timing or referral.

Receiving, storage, and documentation

Each syringe is sterile and single-use. Inspect the carton and blister on arrival, check that the sterile barrier is intact, and confirm the expiry date before the stock joins your par shelf. Follow the storage range printed on the carton, keep syringes in their original packaging to protect them from light, and do not freeze. If syringes have been held cool, many teams let them reach room temperature before injection so the gel flows more easily.

• Log lot number, expiry, and device identifier at goods-in and again in the patient chart.
• Rotate stock by expiry date and review short-dated syringes monthly.
• Do not resterilize, refill, or reuse a syringe, and discard any unused gel after the procedure.
• Discard any syringe with damaged packaging, a loose plunger, or visible particles.
• Keep the instructions for use with the clinical kit for staff reference and training sign-off.

How Durolane compares with other hyaluronic acid injections

Intra-articular hyaluronic acid products differ in schedule, source material, and how the molecule is modified. None of these differences makes one product better for every patient; they affect scheduling, screening, and stock handling.

Quick tip: Keep one printed screening checklist in the injection room so any clinician can confirm allergy history, skin condition, and effusion status before opening a syringe.

Clinic workflow for a single-injection visit

A one-dose protocol still needs a repeatable room setup. Confirm consent and the treated side, prepare the skin, aspirate an effusion if present, then deliver the gel with a clean needle using standard intra-articular technique. Observe the patient briefly, give written aftercare advice, and book the review.

Train all injectors on the same sequence and record competency sign-offs. Where several clinicians share the stock, a simple tally sheet at the storage point keeps counts accurate and makes reordering predictable. Product facts above are drawn from the manufacturer’s instructions for use and FDA device labeling; always read the current documents supplied with your stock before use.

This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.